Exact Mass: 373.2437

Exact Mass Matches: 373.2437

Found 57 metabolites which its exact mass value is equals to given mass value 373.2437, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Curvacin A

(4R)-4-[(1Z,5E,7E,11R)-11-methoxy-8-methyltetradeca-1,5,7,13-tetraen-1-yl]-2-[(1R,2S)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole

C23H35NOS (373.2439)


Production by Lactobacillus curvatus LTH 1174. Bacteriocin.

   

Androsta-5,16-dieno[17,16-b]quinolin-3beta-ol

Androsta-5,16-dieno[17,16-b]quinolin-3beta-ol

C26H31NO (373.2406)


   

Dodecanedioylcarnitine

(4S)-4-[(11-Carboxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C19H35NO6 (373.2464)


Dodecanedioylcarnitine is classified as a tricarboxylic acid or a Tricarboxylic acid derivative. Tricarboxylic acids are carboxylic acids containing exactly three carboxyl groups. Dodecanedioylcarnitine is considered to be a practically insoluble (in water) and a weak acidic compound. Dodecanedioylcarnitine can be found in blood. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

   

O-(11-Carboxyundecanoyl)carnitine

3-[(11-Carboxyundecanoyl)oxy]-4-(trimethylammonio)butanoic acid

C19H35NO6 (373.2464)


O-(11-Carboxyundecanoyl)carnitine is an acylcarnitine. More specifically, it is an dodecanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. O-(11-Carboxyundecanoyl)carnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine O-(11-Carboxyundecanoyl)carnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Leucocrystal Violet

4-{bis[4-(dimethylamino)phenyl]methyl}-N,N-dimethylaniline

C25H31N3 (373.2518)


   

Leucocrystal Violet

Leucocrystal Violet

C25H31N3 (373.2518)


   
   
   

lysylalanylarginine

lysylalanylarginine

C15H31N7O4 (373.2437)


   

alanylarginyllysine

alanylarginyllysine

C15H31N7O4 (373.2437)


   

arginylalanyllysine

arginylalanyllysine

C15H31N7O4 (373.2437)


   
   
   

6-Monoacetylmorphine-3-O-glucuronide

6-Monoacetylmorphine-3-O-glucuronide

C26H31NO (373.2406)


   
   
   

CAR 12:1;O2

3-[(11-carboxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C19H35NO6 (373.2464)


   

tert-Butyl (1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutyl)carbamate

tert-Butyl (1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutyl)carbamate

C21H32BNO4 (373.2424)


   

tert-Butyl 2-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-2(1H)-yl)acetate

tert-Butyl 2-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-2(1H)-yl)acetate

C21H32BNO4 (373.2424)


   
   

Suvn-G3031

Suvn-G3031

C21H31N3O3 (373.2365)


C78272 - Agent Affecting Nervous System

   

16,17-(3,2-Quinolino)androst-5-en-3beta-ol

16,17-(3,2-Quinolino)androst-5-en-3beta-ol

C26H31NO (373.2406)


   
   

2-[4-(1,2-diphenylbutyl)phenoxy]-N,N-dimethylethanamine

2-[4-(1,2-diphenylbutyl)phenoxy]-N,N-dimethylethanamine

C26H31NO (373.2406)


   
   

(4R)-4-[(1Z,5E,7E,11S)-11-methoxy-8-methyltetradeca-1,5,7,13-tetraenyl]-2-[(1R,2S)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole

(4R)-4-[(1Z,5E,7E,11S)-11-methoxy-8-methyltetradeca-1,5,7,13-tetraenyl]-2-[(1R,2S)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole

C23H35NOS (373.2439)


   
   
   

O-dodecanedioylcarnitine

O-dodecanedioylcarnitine

C19H35NO6 (373.2464)


An O-acylcarnitine having 11-carboxyundecanoyl as the acyl substituent.

   
   
   

(2S,3R)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C21H31N3O3 (373.2365)


   

(2R,3S)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C21H31N3O3 (373.2365)


   

(2R,3S)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C21H31N3O3 (373.2365)


   

(2S,3S,3aR,9bR)-1-(cyclohexylmethyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2S,3S,3aR,9bR)-1-(cyclohexylmethyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C21H31N3O3 (373.2365)


   

1-[[(2R,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-3-cyclopentyl-1-ethylurea

1-[[(2R,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-3-cyclopentyl-1-ethylurea

C21H31N3O3 (373.2365)


   

(2R,3R,3aS,9bS)-1-(cyclohexylmethyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2R,3R,3aS,9bS)-1-(cyclohexylmethyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C21H31N3O3 (373.2365)


   

1-[[(2S,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-3-cyclopentyl-1-ethylurea

1-[[(2S,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-3-cyclopentyl-1-ethylurea

C21H31N3O3 (373.2365)


   

1-[[(2S,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-3-cyclopentyl-1-ethylurea

1-[[(2S,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-3-cyclopentyl-1-ethylurea

C21H31N3O3 (373.2365)


   
   
   

2-Cyclohexyl-5-(2-(6-methyl-3-pyridyl)ethyl)-1,2,3,4-tetrahydro-gamma-carboline

2-Cyclohexyl-5-(2-(6-methyl-3-pyridyl)ethyl)-1,2,3,4-tetrahydro-gamma-carboline

C25H31N3 (373.2518)


   
   

O-(11-carboxyundecanoyl)carnitine

O-(11-carboxyundecanoyl)carnitine

C19H35NO6 (373.2464)


An O-acylcarnitine having 11-carboxyundecanoyl as the acyl substituent.

   

Dodecanedioylcarnitine

Dodecanedioylcarnitine

C19H35NO6 (373.2464)


   

O-dodecadienoyl-L-carnitine

O-dodecadienoyl-L-carnitine

C19H35NO6 (373.2464)


An O-acyl-L-carnitine that is L-carnitine having a dodecadienoyl group as the acyl substituent in which the positions of the two double bonds are unspecified.

   
   

(4s)-4-[(1z,5e,7e,11r)-11-methoxy-8-methyltetradeca-1,5,7,13-tetraen-1-yl]-2-[(1r,2s)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole

(4s)-4-[(1z,5e,7e,11r)-11-methoxy-8-methyltetradeca-1,5,7,13-tetraen-1-yl]-2-[(1r,2s)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole

C23H35NOS (373.2439)


   

(2s)-n-[(2s)-1-(1h-indol-3-yl)-3-[(2-methylpropanoyl)oxy]propan-2-yl]-3-methyl-2-(methylamino)butanimidic acid

(2s)-n-[(2s)-1-(1h-indol-3-yl)-3-[(2-methylpropanoyl)oxy]propan-2-yl]-3-methyl-2-(methylamino)butanimidic acid

C21H31N3O3 (373.2365)


   

(4r)-4-[(1z,5z,7z,11r)-11-methoxy-8-methyltetradeca-1,5,7,13-tetraen-1-yl]-2-[(1r,2s)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole

(4r)-4-[(1z,5z,7z,11r)-11-methoxy-8-methyltetradeca-1,5,7,13-tetraen-1-yl]-2-[(1r,2s)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole

C23H35NOS (373.2439)


   

n-[(1s,4s,9r,10s)-5-acetyl-9-[(2z)-hex-2-en-1-yl]-9-hydroxy-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-6,8(12)-dien-6-yl]ethanimidic acid

n-[(1s,4s,9r,10s)-5-acetyl-9-[(2z)-hex-2-en-1-yl]-9-hydroxy-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-6,8(12)-dien-6-yl]ethanimidic acid

C21H31N3O3 (373.2365)


   

n-[5-acetyl-9-(hex-2-en-1-yl)-9-hydroxy-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-6,8(12)-dien-6-yl]ethanimidic acid

n-[5-acetyl-9-(hex-2-en-1-yl)-9-hydroxy-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-6,8(12)-dien-6-yl]ethanimidic acid

C21H31N3O3 (373.2365)


   

(4r)-4-[(5e,7e,11r)-11-methoxy-8-methyltetradeca-1,5,7,13-tetraen-1-yl]-2-[(1r,2s)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole

(4r)-4-[(5e,7e,11r)-11-methoxy-8-methyltetradeca-1,5,7,13-tetraen-1-yl]-2-[(1r,2s)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole

C23H35NOS (373.2439)


   

(4r)-4-[(1z,5e,7z,11r)-11-methoxy-8-methyltetradeca-1,5,7,13-tetraen-1-yl]-2-[(1r,2s)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole

(4r)-4-[(1z,5e,7z,11r)-11-methoxy-8-methyltetradeca-1,5,7,13-tetraen-1-yl]-2-[(1r,2s)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole

C23H35NOS (373.2439)


   

4-(11-methoxy-8-methyltetradeca-1,5,7,13-tetraen-1-yl)-2-(2-methylcyclopropyl)-4,5-dihydro-1,3-thiazole

4-(11-methoxy-8-methyltetradeca-1,5,7,13-tetraen-1-yl)-2-(2-methylcyclopropyl)-4,5-dihydro-1,3-thiazole

C23H35NOS (373.2439)


   

(4r)-4-[(1z,5e,7e,11r)-11-methoxy-8-methyltetradeca-1,5,7,13-tetraen-1-yl]-2-[(2s)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole

(4r)-4-[(1z,5e,7e,11r)-11-methoxy-8-methyltetradeca-1,5,7,13-tetraen-1-yl]-2-[(2s)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole

C23H35NOS (373.2439)